Biohacker's Death Puts DIY Science at a Crossroads

Aaron Traywick lived life as a spectacle with all cameras rolling, so for those who knew him, it wasn't surprising that his death was shrouded in spectacle and controversy, too.

At just 28, Traywick was among the most infamous figures in the world of biohacking—the grandiose CEO of a tiny company called Ascendance Biomedical whose goal was to develop and test new gene therapies without the expense and rigor of clinical trials or the oversight of the FDA.

Read Full Article »
Comment
Show commentsHide Comments

Related Articles